Key result
TRPA1 agonists failed to elicit a response in primary cardiomyocytes and cell lines, and TRPA1 mRNA levels were marginal, excluding a direct effect of TRPA1 in cardiomyocytes.
Why the study?
Despite mounting evidence of a role for TRPA1 in cardiac physiology and pathophysiology, its site of cardiac expression—specifically whether it is expressed in cardiomyocytes—remained unclear.
TRPA1 channels are not functionally expressed in cardiomyocytes, indicating that any cardiac effects of TRPA1 are likely indirect.
Answers are grounded in this paper and cite their sources.
No functional TRPA1 in cardiomyocytes cautions against direct myocyte targeting; leaves open indirect cardiac roles via other cells.
AIM: There is mounting evidence that TRPA1 has a role in cardiac physiology and pathophysiology. We aim to clarify the site of TRPA1 expression in the heart and in particular whether the channel is expressed in cardiomyocytes. METHODS: Due to the high calcium conductance of TRPA1, and marginal calcium changes being detectable, microfluorimetry in primary mouse cardiomyocytes, and in the cardiomyocyte cell lines H9c2 and HL-1, was applied. TRPA1 mRNA in mouse and human hearts, primary cardiomyocytes, and the cardiac cell lines were quantified. Dorsal root ganglia served as control for both methods. RESULTS: In addition to AITC, the more potent and specific TRPA1 agonists JT010 and PF-4840154 failed to elicit a TRPA1-mediated response in native and electrically paced primary cardiomyocytes, and the cardiomyocyte cell lines H9c2 and HL-1. There were only marginal levels of TRPA1 mRNA in cardiomyocytes and cardiac cell lines, also in conditions of cell differentiation or inflammation, which might occur in pathophysiological conditions. Similarly, TRPV1 agonist capsaicin did not activate primary mouse cardiomyocytes, did not alter electrically paced activity in these, and did not activate H9c2 cells or alter spontaneous activity of HL-1 cells. Human pluripotent stem cells differentiated to cardiomyocytes had no relevant TRPA1 mRNA levels. Also in human post-mortem heart samples, TRPA1 mRNA levels were substantially lower compared with the respective dorsal root ganglion. CONCLUSION: The results do not question a role of TRPA1 in the heart but exclude a direct effect in cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Hoebart et al. (2021) studied TRPA1 expression in the heart. TRPA1 agonists (AITC, JT010, PF-4840154) vs. Dorsal root ganglia was evaluated on TRPA1-mediated response and mRNA levels in cardiomyocytes. TRPA1 agonists failed to elicit a response in primary cardiomyocytes and cell lines, and TRPA1 mRNA levels were marginal, excluding a direct effect of TRPA1 in cardiomyocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: